Response to FDA Safety Alert Regarding the Use of Fecal Microbiota for Transplantation
Parsippany, New Jersey – 14 June 2019 – Rebiotix and Ferring Pharmaceuticals were saddened to learn about the patients mentioned…
-
-
Ferring Pharmaceuticals appoints Sophie Opdyke to lead its new U.S. oncology division
Sophie Opdyke will be responsible for building Ferring’s new U.S. oncology division, leading its day-to-day operations, and shaping its long-term…
-
Ferring Pharmaceuticals adds two products to its robust reproductive health portfolio in the U.S.
• Ferring acquired exclusive U.S. commercialization rights for generic Ganirelix Acetate Injection for the prevention of premature ovulation in women…
-
Ferring Pharmaceuticals Enters Exclusive Agreement with INVO Bioscience to Commercialize the Novel INVOcell™ System for Use in the Treatment of Infertility
The INVOcell intravaginal culture (IVC) device uses a woman’s own body as a natural incubator during fertilization and early embryo…
-
NOCDURNA® (desmopressin acetate) Sublingual Tablets Now Available by Prescription in US for Treatment of Nocturia Due to Nocturnal Polyuria
NOCDURNA is the first and only sublingual tablet for the treatment of nocturia due to nocturnal polyuria in adults who…
-
Ferring Introduces ZOMA-Jet® 10, a New Needle-Free Delivery System for Patients Treated with ZOMACTON® 10mg
ZOMA-Jet 10 is a new completely needle-free delivery option available for children and adults being treated with the growth hormone,…
-
Ferring and Celmatix launch ambitious genomics collaboration to advance care in reproductive medicine and women’s health
Research collaboration aims to uncover new insights into ovarian biology and accelerate the development of personalized interventions in reproductive medicine…
-
FDA Approves New Indications for ZOMACTON® (somatropin) as Ferring Plans Launch of Needle-Free Delivery System
ZOMACTON now approved for 5 pediatric and 1 adult indication Ferring will launch ZOMA-Jet® 10 Needle-Free Delivery System for…
-
Ferring’s heat-stable carbetocin could save thousands of women’s lives by preventing excessive bleeding after childbirth
New data show heat-stable carbetocin is as effective as oxytocin, the current standard of care, in preventing excessive bleeding…
-
NOCDURNA® (desmopressin acetate) Now Approved by U.S. FDA as First Sublingual Tablet to Treat Nocturia due to Nocturnal Polyuria
Clinical trials demonstrated an average reduction of nighttime voids of 52% in women and 43% in men relative to mean…